🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/11/2013 | 34,17 | 34,21 | 32,44 | 32,79 | -4,31% | 5,18% | 481.060 |
| 04/11/2013 | 32,75 | 34,42 | 32,74 | 34,27 | +5,45% | 5,10% | 500.296 |
| 01/11/2013 | 32,28 | 33,33 | 31,95 | 32,50 | +0,66% | 4,27% | 415.818 |
| 31/10/2013 | 33,34 | 33,51 | 32,28 | 32,28 | -5,24% | 3,67% | 775.852 |
| 30/10/2013 | 36,00 | 36,35 | 30,57 | 34,07 | -5,76% | 16,06% | 1.628.648 |
| 29/10/2013 | 35,25 | 36,48 | 34,68 | 36,15 | +2,57% | 5,11% | 346.248 |
| 28/10/2013 | 35,70 | 35,87 | 34,67 | 35,25 | -0,88% | 3,35% | 362.118 |
| 25/10/2013 | 35,36 | 35,96 | 34,63 | 35,56 | +0,81% | 3,76% | 244.618 |
| 24/10/2013 | 34,59 | 35,88 | 34,41 | 35,27 | +1,97% | 4,24% | 210.314 |
| 23/10/2013 | 33,84 | 34,83 | 33,59 | 34,59 | +1,80% | 3,65% | 257.923 |
| 22/10/2013 | 34,05 | 34,40 | 33,26 | 33,98 | +0,39% | 3,33% | 366.766 |
| 21/10/2013 | 34,06 | 34,25 | 33,74 | 33,85 | -0,77% | 1,50% | 333.264 |
| 18/10/2013 | 34,31 | 35,25 | 33,76 | 34,11 | +0,42% | 4,35% | 555.440 |
| 17/10/2013 | 30,54 | 34,24 | 30,32 | 33,97 | +11,01% | 12,85% | 667.008 |
| 16/10/2013 | 30,19 | 31,10 | 30,14 | 30,60 | +2,06% | 3,18% | 461.183 |
| 15/10/2013 | 29,74 | 30,11 | 29,59 | 29,98 | +0,78% | 1,76% | 197.169 |
| 14/10/2013 | 29,42 | 30,07 | 29,32 | 29,75 | +0,36% | 2,57% | 222.977 |
| 11/10/2013 | 29,16 | 29,93 | 29,01 | 29,64 | +1,30% | 3,17% | 262.411 |
| 10/10/2013 | 28,50 | 29,26 | 28,46 | 29,26 | +4,55% | 2,82% | 224.741 |
| 09/10/2013 | 28,63 | 28,63 | 27,18 | 27,99 | -2,05% | 5,06% | 293.349 |
| 08/10/2013 | 29,83 | 30,24 | 28,31 | 28,58 | -4,08% | 6,46% | 355.545 |
| 07/10/2013 | 30,03 | 30,56 | 29,54 | 29,79 | -1,87% | 3,41% | 450.764 |
| 04/10/2013 | 30,05 | 30,56 | 29,96 | 30,36 | +1,42% | 1,99% | 331.180 |
| 03/10/2013 | 28,00 | 30,82 | 27,87 | 29,94 | +6,98% | 10,54% | 683.680 |
| 02/10/2013 | 28,12 | 28,38 | 27,50 | 27,99 | -1,36% | 3,15% | 271.388 |
| 01/10/2013 | 26,98 | 28,41 | 26,95 | 28,37 | +5,08% | 5,41% | 669.894 |
| 30/09/2013 | 26,51 | 27,13 | 26,09 | 27,00 | +1,72% | 3,91% | 419.024 |
| 27/09/2013 | 25,46 | 26,73 | 25,46 | 26,54 | +3,73% | 5,00% | 498.533 |
| 26/09/2013 | 25,87 | 25,88 | 24,80 | 25,59 | -1,77% | 4,20% | 1.328.887 |
| 25/09/2013 | 27,42 | 27,45 | 25,99 | 26,05 | -5,13% | 5,35% | 429.764 |